Industrial Chemicals Environmental Management (Register) Principles 2022

The instrument relies on a set of interlocking concepts that translate hazard and use information into schedule placement and then into regulatory specification.

Risk characteristics and schedules

• The central mechanical device is the seven-tier schedule framework. Section 6 requires the Minister to consider whether a relevant industrial chemical exhibits risk characteristics corresponding to Schedule 7 down to Schedule 1. If satisfied a chemical has the characteristic specified for a Schedule, the Minister must list it in that Schedule (s 6(1)-(2)). The instrument sets out the content of each Schedule’s risk characteristics in ss 7-13.

Hazard descriptors drawn from external standards

• Key hazard terms are given technical meanings by reference to external documents. The instrument uses the GHS for definitions of toxic, harmful, harmful to aquatic life, very toxic, bioavailable and harmful (s 4). The Australian PBT Criteria supplies definitions for persistent, bioaccumulative and toxic, and the OECD PFAS terminology document defines “per‑ and polyfluoroalkyl substance” (s 4). This approach externalises scientific standard-setting to named documents that may evolve over time.

Assessed use and measured concentrations

• The classification into Schedules often depends on an “assessed use for a relevant industrial chemical”, defined to include a Commonwealth risk assessment or risk assessments conducted by State bodies, foreign governments or international organisations (s 4). Several Schedule triggers use measured or predicted environmental concentration relative to an “acceptable level for the environment” as a quantitative test,exceeding 1% (Schedule 3), 10% (Schedule 4), or the acceptable level itself (Schedule 5) (see ss 9(4)(b)(i), 10(3)(b)(i), 11(2)(b)(i)). The instrument does not itself define “acceptable level for the environment”, so that term will be sourced elsewhere in the Act or supporting technical material.

Essential use

• For Schedules 7 and 6 the Minister must determine whether the chemical has an “essential use in Australia” and is required to consider a set list of matters when making that determination, including whether an end use is necessary for specific public purposes (medical, veterinary, defence, national security, public safety, industrial safety, economic or environmental), whether viable alternatives exist, whether the chemical is currently used in Australia, and Australia’s international obligations (ss 7(2), 8(2)).

Chemical‑related substances and inorganic components

• The instrument explicitly extends risk consideration to chemical‑related substances, namely substances reasonably expected to form during use, storage or disposal, including by‑products (s 4 def. chemical‑related substance). Separate triggers apply where an inorganic component is present and may become bioavailable (see ss 9(5), 10(4), 11(3)).

Discretion and “appropriateness”

• Throughout the Schedule descriptions and specification sections, the instrument uses “is appropriate to list” and “such risk management measures as the Minister considers appropriate” language (see e.g. ss 7(1)(c), 8(1)(c), 14(2)(c), 15(2)(c), 16(2)(b)). This embeds a broad qualitative appropriateness test into the decision frame while also imposing mandatory considerations in other places.

Specification mechanics

• Once a chemical is to be listed in a Schedule, the instrument prescribes the matters that the Minister must ensure are specified in relation to that chemical as listed. That prescription varies by Schedule:
  • Schedule 7: unless inappropriate, export/import/manufacture and end uses prohibited except for research or disposing in an environmentally sound way; risk management measures must be specified; product/article restrictions can be specified if appropriate; any specified matter must not be inconsistent with international obligations (s 14).
  • Schedule 6: similar to Schedule 7 but allows a third permitted purpose , specified essential uses , and correspondingly to specify restrictions on products/articles; again constrained by international obligations (s 15).
  • Schedule 5/4/3/2: Minister must ensure one or more end uses are specified and appropriate risk management measures for the chemical or for each end use (s 16). For Schedules 4, 3 and 2, the Minister must not specify prohibitions on export/import/manufacture or end uses, or product/article restrictions, except where consistent with international obligations or where exceptional circumstances apply (s 16(4)-(5)).
  • Schedule 1: the Minister must ensure that prohibitions or restrictions on export/import/manufacture and end uses are not specified, and must not specify any end use unless exceptional circumstances apply (s 17).

Interactions with international obligations

• Multiple sections explicitly constrain what can be specified if the specification would be inconsistent with Australia’s international obligations (ss 14(3), 14(5), 15(3), 15(5), 16(3), 17(2)). Those provisions operate as a legal check on unilateral domestic prohibitions in the instrument’s specification regime.

Multiple listings

• The instrument notes that a single chemical may be listed in more than one Schedule (s 6(2) note referencing ss 11(3) and (5) of the Act). This allows overlapping regulatory conditions to be attached to a chemical.

Purpose statement

• The stated purpose is to determine the principles the Minister must comply with in making, varying or revoking scheduling decisions (s 5). The instrument thereby binds Ministerial scheduling decisions to the criteria and specification obligations set out in the instrument.

Collectively these concepts convert hazard and use information into a prescriptive menu of schedule placement and permitted or prohibited activities that the Minister must give effect to when exercising Schedule-related powers under the Act.

The instrument primarily channels regulatory consequences to several identifiable groups by changing what the Minister must specify when a chemical is listed in different Schedules. Those groups are:

• Importers, exporters and manufacturers of industrial chemicals and products containing industrial chemicals. For chemicals listed in Schedule 7 and Schedule 6, the instrument requires the Minister to, unless inappropriate, ensure exportation, importation or manufacture is prohibited except for narrow purposes (research, environmentally sound disposal and, for Schedule 6, specified essential uses) (ss 14(2)(a), 15(2)(a)). The Minister may also specify prohibitions or restrictions on exportation, importation, manufacture or use of products or articles containing the chemical (ss 14(4), 15(4)). Where such prohibitions are specified, businesses that trade in, or produce, the chemical or products containing it will face legally specified constraints.
• Users and purchasers across industry value chains. The instrument requires the Minister to specify permissible end uses or prohibit end uses depending on the Schedule. For Schedule 7 and 6 listings, all end uses are to be prohibited unless for permitted purposes (ss 14(2)(b), 15(2)(b)). For Schedules 5-2 the Minister must specify one or more end uses for the chemical and risk management measures (s 16(2)(a)-(b)). For Schedule 1 the Minister must not specify end uses except in exceptional circumstances (s 17(2)-(3)). These specification outcomes will shape what uses firms can lawfully pursue under the Register.
• Researchers and laboratories. The instrument expressly preserves research and laboratory purposes as permitted uses in the higher-risk Schedules where prohibitions are otherwise required (ss 14(2)(a)(i), 14(2)(b)(i), 15(2)(a)(i), 15(2)(b)(i)). Entities engaged in legitimate research or laboratory activities will therefore occupy an explicitly carved-out legal category for permitted handling, importation and manufacture in those contexts.
• Waste managers and disposers. Environmentally sound disposal is another expressly permitted purpose for importation, exportation or manufacture where higher-level prohibitions are otherwise specified (ss 14(2)(a)(ii), 14(2)(b)(ii), 15(2)(a)(ii), 15(2)(b)(ii)). Waste and disposal service providers may therefore be affected because the instrument contemplates permitted movement or manufacture for disposal purposes.
• Public authorities and regulators. The instrument requires the Minister to consider risk assessments performed by Commonwealth or other government bodies and international organisations when assessing an “assessed use” (s 4 definition of assessed use). This gives weight to non‑Commonwealth technical assessments in the Minister’s decision-making and affects inter‑jurisdictional regulatory work.
• Entities making submissions or providing technical data to the Minister. The instrument’s decision tests require information that many regulated parties hold or can generate , evidence on current use in Australia, viable alternatives, measured or predicted environmental concentrations, bioaccumulative properties, persistence, toxicity to aquatic life, inorganic components and bioavailability, endocrine disrupting properties, and PFAS status (see ss 7-13). Those who can produce such data will influence the Minister’s assessment of essential use, acceptable level exceedance and whether a chemical meets a Schedule’s risk characteristics.
• International trading partners and treaty counterparties. Several provisions limit the Minister from specifying matters that would be inconsistent with Australia’s international obligations (see ss 14(3), 14(5), 15(3), 15(5), 16(3), 17(2)). This means export/import controls that would contravene trade or treaty commitments must be navigated when specifying listing conditions.

Indirect and downstream effects

• Manufacturers of products or articles containing the chemical may be affected even where the primary chemical is not directly traded, since the Minister can specify restrictions on products or articles containing the chemical (ss 14(4), 15(4)). Supply chains that rely on components with the listed chemical will need to track specification outcomes to maintain compliance.
• Substitute producers and trade in alternatives. The instrument requires the Minister to consider the existence of viable alternatives when deciding essential use (ss 7(2)(c), 8(2)(c)). Though the instrument does not itself mandate substitution, its decision framework will influence markets by constraining uses of the listed chemical and thereby creating demand for alternatives.

Notably absent as direct objects of the instrument are criminal penalties, licensing schemes or direct compliance duties for private parties. The instrument mandates what the Minister must consider and specify; it therefore shapes the regulatory constraints that will apply under the Register and any enforcement measures provided elsewhere in the Act. Users and advisers must therefore map the instrument’s specification outcomes into the Act’s operative enforcement and offence provisions to understand direct legal obligations and penalties, because this instrument itself prescribes decision principles and listing‑specification obligations rather than creating enforcement mechanisms.

The instrument creates statutory duties for the Minister and prescribes matters that the Minister must ensure are, or are not, specified in the Register for chemicals listed in particular Schedules. It does not create direct obligations for private parties; instead it determines the specification options the Minister must or must not exercise when issuing scheduling decisions under the Act.

Ministerial duties

• Consideration duty. The Minister must consider whether a relevant industrial chemical has risk characteristics corresponding to Schedules 1-7 when making, varying or revoking a listing decision (s 6(1)). This is a mandatory consideration duty that drives schedule choice.
• Listing duty. If the Minister is satisfied that a chemical has the risk characteristics for a Schedule as defined in the instrument, the Minister must decide to list the chemical in that Schedule (s 6(2) table). The table sets a mandatory mapping from identified risk characteristic types to the corresponding Schedule.
• Specification duties by Schedule. For chemicals to be listed in, or already listed in, a Schedule the Minister must ensure specific matters are specified unless the Minister is satisfied it would be inappropriate (schedular duties differ by schedule):
  • Schedule 7: Unless inappropriate, ensure export/import/manufacture prohibited except for research or environmentally sound disposal purposes; ensure all end uses are prohibited except the same narrow exceptions; ensure appropriate risk management measures are specified (s 14(2)(a)-(c)). The Minister may specify restrictions on products/articles containing the chemical if satisfied appropriate (s 14(4)-(5)). Any such matter must not be inconsistent with Australia’s international obligations (s 14(3), (5)).
  • Schedule 6: Similarly, but permits specified essential uses in addition to research and disposal as exceptions to prohibitions (s 15(2)(a)-(c); s 15(4)-(5)).
  • Schedules 5, 4, 3, 2: Minister must specify one or more end uses and appropriate risk management measures for the chemical or each specified end use (s 16(2)(a)-(b)). The Minister must not specify prohibitions on export/import/manufacture or end uses or product/article restrictions for Schedules 4, 3 or 2, except where consistent with international obligations or exceptional circumstances (s 16(4)-(5)). For Schedule 5, the same absolute prohibition on specifying import/export/manufacture restrictions is not included, so more restrictive measures may be specified subject to other constraints in the instrument or Act.
  • Schedule 1: The Minister must ensure that prohibitions or restrictions on export/import/manufacture and end uses are not specified and must not specify any end use except where exceptional circumstances apply (s 17(2)-(3)).
• Essential use and factors to consider. For Schedules 7 and 6, the Minister must consider whether the chemical has an essential use and, in making that assessment, consider whether the chemical is currently used in Australia, whether end uses are necessary for a list of public purposes, whether viable alternatives exist, and Australia’s international obligations, plus any other relevant matters the Minister considers relevant (ss 7(2), 8(2)).
• Use of external assessments. The definition of “assessed use” incorporates Commonwealth risk assessments and risk assessments by State bodies, foreign governments or public international organisations (s 4). The Minister must consider assessed uses when testing concentration thresholds and effects in some Schedule definitions (for example, ss 9(1)(b), 10(1)(c), 11(1)(c), 12(b)).

Ministerial rights and discretions

• Appropriateness judgement. Frequently the instrument uses “it is appropriate to list” or “as the Minister considers appropriate” language (see ss 7(1)(c), 8(1)(c), 14(2)(c), 15(2)(c), 16(2)(b)). This grants the Minister substantive discretion to evaluate appropriateness when deciding whether to list and what measures to specify.
• Exceptional circumstances carve-outs. For Schedules 4, 3, 2 and 1, the Minister may specify otherwise-prohibited measures if satisfied exceptional circumstances apply (s 16(5) and s 17(3)). These provisions give the Minister a discretionary right to depart from the standard prohibition on specifying certain restrictive matters where the Minister is satisfied of exceptional circumstances.
• International obligations constraint. Several specification duties are qualified by the requirement not to specify matters inconsistent with Australia’s international obligations (ss 14(3), 14(5), 15(3), 15(5), 16(3)). That qualification forces the Minister to weigh treaty obligations or trade commitments when shaping regulatory instruments.

Duties that follow from definitions and thresholds

• Technical evidentiary duties. Because many Schedule triggers hinge on quantitative thresholds (measured or predicted environmental concentrations versus “acceptable level for the environment”) and on attributes such as persistence, bioaccumulation, toxicity, and endocrine disruption, the Minister must, in practice, evaluate or source scientific and technical evidence to be “satisfied” that the chemical meets those criteria (see ss 7-13). The instrument defines “assessed use” to include assessments by specified bodies (s 4), which creates a statutory right for the Minister to rely on those assessments as part of satisfaction of thresholds.

Rights of regulated parties (implicit)

• The instrument does not create explicit appeal rights, exemption mechanisms or compensation mechanisms; those will be contained in the Act or other operative instruments. What the instrument does afford indirectly is the procedural pathway to argue around listing outcomes: interested parties can reasonably expect that producing risk assessments, demonstrating viable alternatives, showing limited or no current use in Australia, or demonstrating international obligations will be material to the Minister’s satisfaction on essential use and appropriateness (see ss 7(2), 8(2), 16 and related definitions). The instrument therefore shapes what technical inputs are relevant to persuade the Minister.

Overall, the instrument places mandatory obligations on the Minister to classify chemicals according to defined risk criteria and to specify or withhold particular regulatory matters in the Register according to the Schedule. It sets the topics of inquiry and the universe of acceptable specification outcomes, while leaving practical implementation and enforcement to the Act and subsequent Register entries.

The instrument itself prescribes decision-making principles and specification obligations for the Minister; it does not create criminal offences, civil penalties, compliance regimes, or enforcement procedures. The instrument is made under s 23(1) of the Industrial Chemicals Environmental Management (Register) Act 2021 (s 3), and its contents are limited to specifying the principles the Minister must comply with and the matters the Minister must or must not specify in the Register for each Schedule (see ss 5, 6, 14-17). As such, it is a rule-making instrument for the executive decision process rather than a standalone enforcement statute.

Consequently:

• The instrument does not state any penalties for non-compliance by private parties with specified outcomes. Where the Minister specifies prohibitions or restrictions on exportation, importation, manufacture or end uses in the Register under the Act, those prohibitions may be enforceable under the Act or other legislation. The instrument itself does not set out those enforcement mechanisms. Readers must consult the Act and any subordinate instruments that give effect to Register specifications for details on offences, sanctions, compliance mechanisms, licensing, and administrative penalties.
• The instrument imposes mandatory duties on the Minister (for example, to ensure certain matters are specified or not specified for listings in particular Schedules). Failure by the Minister to comply with the instrument’s mandatory requirements could give rise to administrative law remedies such as judicial review of the Minister’s decision under public law principles, but the instrument does not itself explain remedies or jurisdiction. Any reviewability or remedies will flow from the Act, general administrative law principles and judicial processes rather than from this instrument’s text.
• The instrument references external technical standards (GHS, Australian PBT Criteria, OECD PFAS document) to define terms such as “toxic”, “persistent”, “bioaccumulative” and “per‑ and polyfluoroalkyl substance” (s 4). Compliance with Register specifications that rely on those definitions will likely require evidence and testing consistent with those standards; enforcement of specified conditions will therefore hinge on technical proof aligned to those referenced documents.

Implementation and enforcement risk areas

• Translating specification outcomes into enforceable obligations requires the Minister to exercise the specification powers available under the Act. For example, even though the instrument mandates that the Minister ensure prohibitions are specified for Schedule 7 chemicals unless inappropriate (s 14(2)), the practical enforcement of those prohibitions depends on the Act’s operative powers to give binding effect to Register specifications and any associated sanctions, which this instrument does not enumerate.
• The instrument’s repeated qualification that specified matters must not be inconsistent with Australia’s international obligations (ss 14(3), 14(5), 15(3), 15(5), 16(3)) may constrain the scope of domestic prohibitions in a way that affects enforceability against foreign trade counterparts. Where prohibitions are limited by treaty obligations or trade law, enforcement may require coordination with customs, quarantine, trade or other national agencies, none of which are addressed in the instrument.

Practical consequence for regulated parties

• Businesses and other regulated parties should treat the instrument as setting the decision rules that will determine whether a chemical is categorised into a Schedule that carries regulatory constraints. The actual penalties and compliance requirements applicable to regulated parties will arise only from the Register entries made under the Act and the Act’s enforcement provisions. Advisers should therefore map the instrument’s specification outcomes (what the Minister is to specify) carefully against the Act to identify the operative legal obligations and associated penalties that will apply once the Minister makes a scheduling decision.

In short, enforcement is outside the instrument’s text and exists in the Act and other operative laws; this instrument shapes the content and scope of the binding Register entries that will ultimately be enforced under those laws.

The instrument is designed to operate within the legal architecture established by the Industrial Chemicals Environmental Management (Register) Act 2021 and to interface with other technical and international instruments. The instrument repeatedly ties its operation to external standards, assessments and Australia’s international obligations; these interactions determine the instrument’s practical reach and constraints.

Interaction with the parent Act

• The instrument is expressly made under s 23(1) of the Act (s 3). It sets principles the Minister must comply with when making scheduling decisions under the Act (s 5). Therefore the instrument does not itself create the administrative machinery for listing, enforcement, or appeal; those procedural and enforcement aspects are governed by the Act. For operational effect, the Register and any sanctions, compliance tools, or administrative review rights must be located in the Act or in other delegated instruments that implement the Register entries in practice.

Reliance on international and technical standards

• The instrument imports technical definitions by reference to other documents, making its application dependent on those instruments:
  • GHS: The instrument uses the Globally Harmonized System of Classification and Labelling of Chemicals to define concepts such as toxic, harmful, harmful to aquatic life, very toxic, bioavailable and harmful (s 4). This ties the instrument’s hazard language to internationally accepted classification criteria.
  • Australian PBT Criteria: Persistence, bioaccumulative and toxic meanings are drawn from the Australian Environmental Criteria for Persistent, Bioaccumulative and/or Toxic Chemicals (s 4). The PBT criteria supply critical definitions used in Schedules 7, 6 and 5.
  • OECD PFAS document: The instrument adopts the OECD document Reconciling Terminology of the Universe of Per‑ and Polyfluoroalkyl Substances for the definition of per‑ and polyfluoroalkyl substances (s 4). This creates a cross‑reference to international PFAS terminology work when identifying PFAS for Schedules 5 and 4 triggers.
• Because those documents can evolve over time, the instrument’s substantive meaning can change as the referenced documents are updated, unless the Act or external document links fix a specific version. The instrument, for example, references the GHS “as existing from time to time” (s 4), meaning future GHS revisions will feed into the instrument’s definitions.

Interaction with other domestic regulatory regimes

• The instrument’s content may overlap or intersect with other Australian regulatory frameworks for chemicals, products, waste, import/export control, occupational health and safety, and environmental protection. For instance:
  • Export/import restrictions specified in the Register for Schedule 7 and Schedule 6 chemicals have potential interface effects with customs, quarantine and trade regulation, though the instrument limits specification where inconsistent with Australia’s international obligations (ss 14(3), 14(5), 15(3), 15(5)).
  • Risk management measures the Minister may specify for particular end uses (s 16(2)(b)) could duplicate or complement requirements under state environmental protection laws, the work health and safety regime, product safety laws and chemical control frameworks. The instrument does not displace those regimes; it sets the Register’s specification content which must be aligned with other legal requirements.
• The instrument authorises the Minister to take into account assessments by State bodies and foreign government bodies (s 4, definition of assessed use). That creates a mechanism for the Register to align with State‑level assessments or foreign regulatory decisions, potentially enabling regulatory coherence or, conversely, regulatory divergence if different standards are relied upon.

International obligations and trade law

• Multiple provisions forbid specifying matters that would be inconsistent with Australia’s international obligations in respect of the chemical (ss 14(3), 14(5), 15(3), 15(5), 16(3), 17(2)). These clauses force coordination between domestic regulatory action and international commitments, including treaties and trade obligations. Where the Minister proposes export/import or use restrictions, those clauses require an assessment of whether such restrictions would breach obligations under international agreements or treaties before they are specified in the Register.

Evidence and standards of proof

• Schedule tests often depend on measured or predicted environmental concentrations and “acceptable level” thresholds (for example, ss 9(4)(b)(i), 10(3)(b)(i), 11(2)(b)(i)). Because the instrument does not define “acceptable level for the environment”, the Minister will need to rely on the Act, subordinate guidance, or scientific instruments to operationalise that term. That introduces cross‑reference interaction with any domestic technical guidance or standards that define acceptable levels for environmental contaminants.

Administrative law and review

• The instrument imposes mandatory duties on the Minister; administrative law principles will define whether the Minister’s decisions under the instrument are amenable to judicial review, and on what grounds. The instrument does not itself set appeal or review mechanisms. Therefore any interactions with judicial review, merits review bodies or tribunal processes will be governed by the Act and general administrative law. The degree to which affected parties can challenge schedule placements, specification choices, or the Minister’s assessment of essential use will depend on the Act and general administrative law doctrine.

In summary, the instrument integrates with the Act and multiple external standards and obligations. It provides a decision rubric for the Minister that interfaces with international trade law, technical standards, state and federal assessments, and other chemical regulatory regimes. Its practical effect depends on the Act’s operative provisions and the referenced technical documents.

The instrument contains a short recorded history limited to its original making and commencement. The relevant entries in the instrument itself are:

• Date of making: The instrument is signed by Tanya Plibersek, Minister for the Environment and Water, and dated 7 November 2022 (front matter).
• Commencement: The instrument’s commencement provision states the whole instrument commences the day after registration, recorded as 9 November 2022 (s 2 and the commencement table). The table indicates the commencement detail: “The whole of this instrument” commenced on “The day after this instrument is registered. 9 November 2022.” The instrument notes that the table relates only to the provisions as originally made and will not be amended to reflect later amendments (s 2 note).
• Instrument-making authority: The instrument is made under subsection 23(1) of the Industrial Chemicals Environmental Management (Register) Act 2021 (s 3). This identifies the statutory source of the instrument and thus any amendment powers will be those conferred by the Act.
• External document versions: Several definitions are framed by reference to named external documents “as existing on the commencement of this instrument” or “as existing from time to time.” For example, “Australian PBT Criteria means the document titled Australian Environmental Criteria for Persistent, Bioaccumulative and/or Toxic Chemicals published by the Department and as existing on the commencement of this instrument” (s 4). For GHS, the instrument uses the version “as existing from time to time” (s 4). These cross‑references mean the instrument was tied to specific versions on commencement in some cases and to dynamic versions in others. The text therefore records which external documents were to be treated as authoritative at commencement.
• Notes: The instrument includes a note that column 3 of the commencement table is not part of the instrument and may be edited in any published version (s 2(2)). That is a drafting housekeeping detail rather than an amendment history.

The instrument as presented contains no subsequent amendments, replacement texts or amendment dates. Because the instrument is tied to the Act, any amendment to the instrument after commencement would be accomplished by the appropriate executive process under the Act’s delegated instrument-making power. Users seeking a complete and current amendment history should consult the Federal Register of Legislation or the database where instruments and their amendments are published; the instrument itself records only its original making and commencement dates.

The instrument does not include any record of litigation and the text contains no references to court or tribunal decisions. It is a policy and decision‑making instrument defining criteria for Ministerial scheduling decisions under the Industrial Chemicals Environmental Management (Register) Act 2021. The instrument itself does not create offences or penalties and does not institute administrative review processes; consequential enforcement and review questions will be resolved under the Act and general administrative law.

Because the instrument imposes mandatory duties on the Minister (for example, to list a chemical in a Schedule if satisfied the chemical has particular risk characteristics, s 6(2)), affected parties might seek administrative law remedies such as judicial review if they allege the Minister failed to apply the instrument’s mandatory provisions or acted unreasonably. The instrument does not comment on the availability of such remedies; any judicial interpretation or litigation about the instrument would rely on the Act as well as standard public law grounds (for example, procedural fairness, jurisdictional error, reasonableness). The instrument itself contains no litigation summary, appeal mechanism or tribunal reference.

To determine whether any litigation has arisen from this instrument in practice, practitioners must search judicial databases and governmental records after the instrument’s commencement date (9 November 2022). The instrument as supplied contains no litigation history entries, no named cases, and no administrative decisions.

This instrument contains specific drafting choices and technical dependencies that create practical pitfalls for regulators, industry and advisers. The following points identify concrete legal and operational issues that arise directly from the instrument’s text.

Reliance on external definitions that can change

• The instrument imports technical meaning from external documents (GHS, Australian PBT Criteria, OECD PFAS). Some references are expressly tied to the version “as existing on the commencement of this instrument” (Australian PBT Criteria, OECD PFAS document), while the GHS reference is “as existing from time to time” (s 4). Practically, this means the meaning of terms such as “toxic”, “persistent”, “bioaccumulative” and “per‑ and polyfluoroalkyl substance” may drift as those documents are updated. That has legal significance because the Minister’s satisfaction that a chemical meets Schedule criteria depends on these definitions. Advisers should note which references are fixed to the commencement version and which are dynamic.
• The instrument does not define “acceptable level for the environment”, yet several Schedule triggers hinge on measured or predicted environmental concentration exceeding a percentage of that acceptable level (ss 9(4)(b)(i), 10(3)(b)(i), 11(2)(b)(i)). The absence of a definition in the instrument creates uncertainty as to where that standard will be sourced and how it will be operationalised.

Quantitative thresholds require scientific modelling and consensus

• Tests that refer to measured or predicted environmental concentrations relative to percentages of an “acceptable level” require modelling assumptions, monitoring data, and scientific judgment. The instrument allows the Minister to rely on assessed uses conducted by state, foreign or international bodies (s 4), which may produce divergent methodologies. The Minister’s choice of which assessments to accept can materially affect schedule placement, so stakeholders should be prepared to provide robust, transparent modelling aligned with accepted methods and to dispute inappropriate modelling choices on administrative law grounds.

“Appropriate” and “exceptional circumstances” are open standards

• Multiple provisions require the Minister to be “satisfied it is appropriate to list” or to specify “such risk management measures as the Minister considers appropriate” (see, for example, ss 7(1)(c), 14(2)(c), 15(2)(c)). Similarly, ss 16(5) and 17(3) allow specification of otherwise prohibited matters if the Minister is satisfied that “exceptional circumstances” apply. These open standards give the Minister wide latitude. Parties seeking predictability should supply the Minister with evidence-based criteria that define what constitutes “appropriate” measures or “exceptional circumstances” in a given context.

Overlap and multiple listings

• The instrument allows a chemical to be listed in more than one Schedule (s 6(2) note). Overlapping schedule listings could create complex regulatory obligations and potentially conflicting specification conditions (for example, a chemical listed simultaneously in a Schedule that calls for prohibition except for narrow purposes and a Schedule that lists permitted end uses). Practitioners should anticipate that an entry in the Register could attach multiple, cumulative specification obligations and examine Register entries carefully.

Essential use test requires evidence of alternatives and necessity

• For Schedules 6 and 7 the Minister must decide whether a chemical “does not have an essential use” (Schedule 7) or “has one or more essential uses” (Schedule 6) and must consider whether viable alternatives exist (ss 7(2), 8(2)). That turns on evidence of current use in Australia, necessity for enumerated public purposes, and viable alternatives. The instrument’s construction means that industry submissions that do not address viable alternatives or the necessity of the end use are unlikely to be persuasive.

PFAS and endocrine disruptor provisions

• The instrument singles out per‑ and polyfluoroalkyl substances and endocrine disruptors in Schedule 5 and Schedule 4 triggers (ss 9(3), 10(2)(b)). Because PFAS is defined by reference to an OECD document, and endocrine disruptor is defined broadly in the instrument (s 4), these categories can trigger listing on a relatively lower evidentiary threshold if persistence and disruption are demonstrated. Parties dealing with PFAS should ensure their technical assessments map precisely to the OECD definition referenced.

Inorganic components require attention to bioavailability

• Several triggers rest on an inorganic component being in a form that “is, or could become, bioavailable” (ss 9(5)(b), 10(4)(b)). Demonstrating non‑bioavailability is therefore potentially decisive for avoiding higher schedule placement. Laboratory testing and exposure pathway analysis will be central to that demonstration.

International obligations constrain domestic measures

• Multiple clauses prevent the Minister from specifying prohibited matters if doing so would be inconsistent with Australia’s international obligations (for example, ss 14(3), 15(3), 16(3)). A common “gotcha” is assuming the instrument permits unilateral domestic import/export prohibitions without legal constraint. Where a proposed specification would conflict with treaty or trade obligations, the Minister is statutorily required to avoid inconsistency.

Register specifications versus operational enforcement

• The instrument mandates what must be specified in the Register for each Schedule but does not articulate how those specifications will be enforced, what licencing regimes (if any) will apply, or what penalties will attach. Stakeholders must map Register specifications into enforcement rules in the Act and other relevant statutes to ascertain practical legal exposure.

No penalties or appeal mechanisms in the instrument

• Because the instrument does not set out penalties, reporting duties, or appeal mechanisms, affected parties should not assume the instrument itself provides procedural safeguards. Instead, they must consult the Act and subordinate instruments for modes of compliance, enforcement, and review.

In practice these “gotchas” mean regulated parties should focus on robust scientific evidence, anticipate broad ministerial discretion, align submissions to the external standards referenced by the instrument, and plan for cross‑jurisdictional legal constraints arising from international obligations.

Compliance with the outcomes that will flow from this instrument is primarily about preparing for the kinds of Schedule listings and specification outcomes the instrument mandates and ensuring evidence and submissions are geared to the instrument’s decision criteria. The instrument itself binds the Minister; compliance by private parties occurs once the Minister specifies prohibitions, permitted uses and risk management measures in the Register under the Act. The following pragmatic steps map what the instrument requires to actions available to industry, advisers and public authorities.

1. Understand the Schedule triggers and their evidence needs

• Map the chemical to the instrument’s Schedule tests in ss 7-13. Determine which characteristics apply: persistence, bioaccumulation, toxicity, endocrine disruption, PFAS status, aquatic toxicity, inorganic bioavailability, and expected environmental concentrations under assessed uses.
• For quantitative tests (measured or predicted environmental concentration relative to “acceptable level for the environment”), obtain or prepare robust environmental fate and transport modelling and monitoring data. Since the instrument does not define “acceptable level for the environment”, identify and cite the applicable standard or technical guidance (from the Act’s supporting materials or authoritative environmental thresholds used by competent authorities).
• If the chemical contains inorganic components, commission bioavailability testing and interpret results against the instrument’s bioavailability tests (ss 9(5), 10(4), 11(3)).

2. Prepare and source authoritative risk assessments

• The Minister may rely on Commonwealth, State, foreign government or public international organisation assessments in treating an end use as an “assessed use” (s 4). Where possible, obtain or reference authoritative risk assessments from recognised bodies to support the chemical’s assessed use profile.
• Ensure risk assessments explicitly address the factors the instrument requires the Minister to consider (for example, persistence, bioaccumulation, aquatic toxicity and endocrine disruption) and present data in the terms used by the instrument (GHS classifications, PBT criteria, PFAS definitions).

3. Address essential use and alternatives

• If seeking to avoid Schedule 7 or to secure a Schedule 6 listing with specified essential uses, prepare a structured essential use submission that directly addresses ss 7(2) and 8(2): demonstrate whether the chemical is currently used in Australia, show necessity for one of the stated public purposes (medical, veterinary, defence, national security, public safety, industrial safety, economic or environmental), and provide evidence on viable alternatives (comparative performance, availability, economic viability, and risk profiles).
• Provide comparative life‑cycle or substitution analyses where relevant. The instrument explicitly instructs the Minister to consider viable alternatives (ss 7(2)(c), 8(2)(c)), so this evidence is material.

4. Develop risk management measures aligned to end uses

• For Schedules 5-2 the Minister must specify one or more end uses and “such risk management measures” for the chemical or each specified end use as the Minister considers appropriate (s 16(2)). Draft proposals for workable risk management measures tailored to specific end uses, including engineering controls, labelling, packaging, exposure limits, transport and disposal requirements, and monitoring regimes. Present these proposals in technical detail so the Minister can incorporate them into Register specifications without extensive reworking.
• Ensure any proposed risk management measures align with GHS labelling and classification standards referenced in the instrument (s 4).

5. Consider international obligations and trade implications

• If the Register entry could restrict exportation, importation or manufacture, assess whether proposed specifications would be consistent with Australia’s international obligations. The instrument forbids specifying matters inconsistent with those obligations (e.g. ss 14(3), 14(5), 15(3), 15(5), 16(3), 17(2)). Prepare legal memoranda identifying any relevant treaties, WTO commitments, or trade agreements that could be implicated, and propose specification language that meets environmental objectives while respecting international obligations.

6. Prepare for possible product or article restrictions

• For Schedule 7 or 6 listings, the Minister may, if satisfied it is appropriate, specify prohibitions or restrictions on products or articles containing the chemical (ss 14(4), 15(4)). If the chemical is present in downstream products, map supply chains and be ready to present data on concentrations, exposure pathways and feasibility of reformulation or substitution.

7. Engage early with regulators and participate in consultations

• Because the Minister must be “satisfied” that specific criteria are met and has broad discretion over “appropriateness”, engage early in any public consultation processes and provide targeted technical submissions. Focus submissions on the instrument’s listed considerations: current use in Australia, necessity for enumerated public purposes, viable alternatives, measured/predicted environmental concentrations, and alignment with external standards (s 7(2), s 8(2), s 4).
• Where possible, align submissions with accepted scientific methods used in the GHS and the Australian PBT Criteria.

8. Document assumptions and modelling transparently

• Because several Schedule triggers depend on predicted environmental concentrations and exceedances of “acceptable levels”, document modelling assumptions, input data, fate and transport parameters, and sensitivity analyses thoroughly. Transparent documentation will be essential if the Minister relies on your data or if a decision is challenged.

9. Prepare operational compliance plans

• Anticipate the Register’s specification outcomes and prepare implementation plans for each scenario: full prohibition (Schedule 7), restricted essential use with specific controls (Schedule 6), permitted end uses with risk management measures (Schedules 5-2), and minimal specification (Schedule 1). Include supply chain continuity planning, disposal solutions aligned to permitted “environmentally sound disposal” provisions (ss 14(2)(a)(ii), 15(2)(a)(ii)) and redesign or reformulation timelines if necessary.

10. Seek legal and technical advice on appeal and review

• The instrument itself does not provide appeal mechanisms; any review route will be under the Act or general administrative law. If subject to an adverse Register specification, seek advice on available administrative remedies, including judicial review grounds (for example, procedural fairness or jurisdictional error), and on strategic engagement to present new evidence or to ask the Minister to vary or revoke a scheduling decision.

By aligning technical evidence and submissions to the instrument’s specified decision criteria and external standards, affected parties will be positioned both to influence scheduling outcomes and to prepare for the operational consequences of the Schedule listings and Register specifications that flow from those outcomes.